Large-scale testing (Phase 3)Study completedNCT01650701
What this trial is testing
Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma
Who this might be right for
Follicular Lymphoma
The Lymphoma Academic Research Organisation 1,030